Details for New Drug Application (NDA): 022500
✉ Email this page to a colleague
The generic ingredient in NEXICLON XR is clonidine. There are twenty-two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the clonidine profile page.
Summary for 022500
Tradename: | NEXICLON XR |
Applicant: | Athena |
Ingredient: | clonidine |
Patents: | 2 |
Pharmacology for NDA: 022500
Mechanism of Action | Adrenergic alpha2-Agonists |
Medical Subject Heading (MeSH) Categories for 022500
Suppliers and Packaging for NDA: 022500
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NEXICLON XR | clonidine | TABLET, EXTENDED RELEASE;ORAL | 022500 | NDA AUTHORIZED GENERIC | TruPharma, LLC | 52817-375 | 52817-375-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52817-375-30) |
NEXICLON XR | clonidine | TABLET, EXTENDED RELEASE;ORAL | 022500 | NDA AUTHORIZED GENERIC | PALMETTO PHARMACEUTICALS INC. | 68134-603 | 68134-603-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68134-603-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 0.17MG BASE | ||||
Approval Date: | Dec 3, 2009 | TE: | RLD: | No | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 17, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 8, 2031 | Product Flag? | Y | Substance Flag? | Delist Request? |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 0.26MG BASE | ||||
Approval Date: | Dec 3, 2009 | TE: | RLD: | No | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 17, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription